BDBM50139079 (S)-2-{[2-(Toluene-4-sulfonyl)-2-aza-bicyclo[2.2.2]octane-3-carbonyl]-amino}-3-[4-(2,4,6-trichloro-benzoylamino)-phenyl]-propionic acid::CHEMBL347480

SMILES Cc1ccc(S(=O)(=O)N2C3CCC(CC3)C2C(=O)N[C@@H](Cc2ccc(NC(=O)c3c(Cl)cc(Cl)cc3Cl)cc2)C(=O)O)cc1

InChI Key InChIKey=DAXARQWUAAGHQQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50139079   

TargetIntegrin alpha-4/beta-1(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50139079BDBM50139079((S)-2-{[2-(Toluene-4-sulfonyl)-2-aza-bicyclo[2.2.2...)
Affinity DataIC50: 51nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed